Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

INBXINBX

Showing 8 of 9 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in INHIBRX BIOSCIENCES INC

Yes. Viking Global Investors holds 1,123,929 shares of INBX (Inhibrx Biosciences), worth $106.5M, as of its Q2 2026 13F filing. It reduced the position by 313,776 shares (-21.8%) from Q1 2026. Viking Global Investors has held INBX in every 13F on record since Q2 2024, 9 quarterly filings. INBX is 0.3% of Viking Global Investors' reported 13F portfolio.

Current Value

$106.5M

Current Shares

1.1M

Total Value Change

+$78.5M

Total Shares Change

-663,776

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.1M
-21.8%
$106.5M0.3%$94.75
0
2026-Q1
Unchanged
1.4M
0.0%
$96.7M0.3%$74.33
0
2025-Q4
Decreased
1.4M
-19.6%
$113.6M0.3%$77.98
0
2025-Q3
Unchanged
1.8M
0.0%
$60.2M0.2%$32.31
0
2025-Q2
Unchanged
1.8M
0.0%
$25.5M0.1%$14.43
0
2025-Q1
Unchanged
1.8M
0.0%
$25M0.1%$14.12
0
2024-Q4
Unchanged
1.8M
0.0%
$27.5M0.1%$15.14
0
2024-Q3
Unchanged
1.8M
0.0%
$28M0.1%$15.52
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used